-
GSK’s B7-H3-targeted antibody-drug conjugate, GSK’227 gets EMA PRIME designation in relapsed extensive-stage small-cell lung cancer
21 Dec 2024 12:26 GMT
… relapsed extensive-stage small-cell lung cancer (ES-SCLC).
The PRIME … in locally advanced or metastatic solid tumours, including relapsed … 2024 World Conference on Lung Cancer earlier this year. GSK … Pharma for the treatment of lung cancer, sarcoma, head and …
-
Any Betta? FDA adds Ensacove to ALK lung cancer weaponry
19 Dec 2024 23:01 GMT
… U.S. non-small-cell lung cancer (NSCLC) arena as the U … (ALK)-positive locally advanced or metastatic disease who have not previously …
-
FDA approves ensartinib for metastatic non-small cell lung cancer
19 Dec 2024 19:40 GMT
… -positive locally advanced or metastatic non-small cell lung cancer.
The indication applies … -positive locally advanced or metastatic non-small cell lung cancer. Image: Adobe Stock … locally advanced or metastatic ALK-positive non-small cell lung cancer who had …
-
FDA Approves Ensartinib for Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer
19 Dec 2024 19:10 GMT
… -positive locally advanced or metastatic non–small cell lung cancer (NSCLC) who have … positive locally advanced or metastatic non-small cell lung cancer. News release. December … positive-locally-advanced-or-metastatic-non-small-cell-lung-cancer
2. eXalt3: …
-
U.S. FDA Approves Pfizer’s BRAFTOVI® Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer
20 Dec 2024 19:17 GMT
… drugs for advanced or metastatic disease.
“Historically, treatment … patients diagnosed with metastatic colorectal cancer with … for those receiving a metastatic colorectal cancer diagnosis … thoracic cancers, which includes lung cancer. Driven by science, we …
-
Gilead Sciences earns USFDA Breakthrough Therapy Designation for lung cancer treatment Trodelvy
19 Dec 2024 13:06 GMT
… 2024 World Conference on Lung Cancer, Trodelvy demonstrated promising … deaths. Approximately 15% of lung cancer cases are SCLC, … 90% of breast and lung cancers. Trodelvy is intentionally … cell lung cancer and first-line metastatic non-small cell lung cancer …
-
FDA Approval of Ensartinib for ALK-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
19 Dec 2024 03:35 GMT
… )-positive locally advanced or metastatic non-small cell lung cancer (NSCLC). This approval … ALK-positive locally advanced or metastatic NSCLC.
About Xcovery
Xcovery is … tumors with a focus on lung cancer.
Forward‐Looking Statements
This press …
-
Plus Therapeutics presents ReSPECT─LM phase 1 trial data for breast cancer patients with leptomeningeal metastases
20 Dec 2024 13:12 GMT
… cancer associated with leptomeningeal metastases,” said Marc H. … expansion trial.”
Leptomeningeal Metastases is a rare complication … developing LM. Additionally, lung cancer, GI cancers and melanoma … glioblastoma and leptomeningeal metastases in the ReSPECT- …
-
FDA approves ensartinib for ALK-positive locally advanced or metastatic non-small cell lung cancer
18 Dec 2024 21:08 GMT
… )-positive locally advanced or metastatic non-small cell lung cancer (NSCLC) who have … patients with locally advanced or metastatic ALK-positive NSCLC who had …
-
Drug-Eluting Beads Bronchial Arterial Chemoembolization Combined with Immunotherapy Resulted in Pathological Complete Response of Squamous Cell Lung Cancer: A Case Report
18 Dec 2024 16:06 GMT
… candidate drug for treating lung cancer. Importantly, epirubicin … et al. Metastatic non-small-cell lung cancer: ESMO clinical … arterial chemoembolization in lung cancer patients with hemoptysis. … pathologic assessment of lung cancer resection specimens after …
About
© 1995-2024